Quarterly ResultMay 8, 2026, 04:52 PM
Creative Medical Q1 Net Loss $(1.40M); Revenue $0
AI Summary
Creative Medical Technology Holdings, Inc. reported a net loss of $(1.40) million for the three months ended March 31, 2026, an improvement from $(1.64) million in the prior year. However, revenues for the quarter dropped to $0 from $3,000 in Q1 2025. The company's cash balance decreased to $5.72 million from $7.21 million at December 31, 2025, and total assets also declined.
Key Highlights
- Net loss for Q1 2026 was $(1.40) million, an improvement from $(1.64) million in Q1 2025.
- Revenues for Q1 2026 were $0, a decrease from $3,000 in Q1 2025.
- Net loss per share improved to $(0.38) in Q1 2026 from $(0.83) in Q1 2025.
- Cash balance as of March 31, 2026, was $5.72 million, down from $7.21 million at December 31, 2025.
- Total assets decreased to $6.44 million as of March 31, 2026, from $7.81 million at December 31, 2025.
- Research and development expenses decreased to $541,658 in Q1 2026 from $743,304 in Q1 2025.
- Net cash used in operating activities was $(1.32) million in Q1 2026, an improvement from $(1.59) million in Q1 2025.
- Net cash provided by financing activities was $13,360 in Q1 2026, significantly down from $3.35 million in Q1 2025.